Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
about
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic processNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Are Periventricular Lesions Specific for Multiple Sclerosis?Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC."Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies.A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation proceduresDiffusion Weighted Imaging in Acute Attacks of Multiple Sclerosis.Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.Therapeutic management of severe relapses in multiple sclerosis.Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis.Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
P2860
Q29542960-48D89989-9CB1-46B1-A6FA-6CBEF5808727Q30576477-44F7BCB2-F923-4847-9925-4C134A6E2BA5Q34820765-0B20C95A-8E9A-4869-81EB-025DE1E38239Q35024646-0F552991-7462-497D-9607-0544961EBCA4Q35027564-A7070442-104C-4348-B829-5D034DD33D17Q35893074-653541E5-6965-4C5B-A214-1ABE93095E83Q37281707-3E135D97-7703-466C-A9E9-BF0762FF41E0Q37351065-8846CAE3-2956-403A-AA85-3D2D31BB60B9Q39026942-053CF95B-FC7A-459E-8D5D-98D43542CE1FQ39473471-4E33DCFD-EDBB-4274-9A7E-1F88E75C8FA6Q39902923-1952E8F1-468B-470B-97AC-1F2A1FBCDFBCQ43451141-9D67A72F-22CD-4F9B-8EA3-258FCDD30901Q43981672-094CF094-42C9-41A8-9E86-1546FE61D7D8Q52097042-A04B7AA2-06E7-4A9A-8B71-CE513DBB1413Q57490936-4C99CD78-4BE7-46F9-A974-D86BA37967DC
P2860
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@ast
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@en
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@nl
type
label
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@ast
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@en
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@nl
prefLabel
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@ast
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@en
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@nl
P2860
P356
P1476
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
@en
P2093
Eric Lindzen
Konstantin E Balashov
P2860
P304
P356
10.1177/1352458512445407
P577
2012-04-20T00:00:00Z